1,444Women,developed,Obj
1,444Women,developedCbcDuring,Obj
12-15Percecnt,are,triple-negativeBreastCancers,Obj
12SampledWomen,isWith,femaleSibling,Obj
18f-fdgPet/ctImages,were,compared,Obj
18f-fdgPet/ctImages,were,comparedSemi-quantitatively,Obj
24ApplicableCases,of13Is,54Percecnt,Obj
24Cases,isWith,metastaticDiseaseOnPresentation,Obj
466Percecnt,had,familyMemberAffectedWithCancer,Obj
466Percecnt,overallHad,familyMemberAffectedWithCancer,Obj
95PercecntConfidenceIntervals,were,estimated,Obj
acromegaly,was,higher,Obj
acromegaly,wasSignificantlyHigherThan,thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas,Obj
adjustment,was,factor,Obj
adjustment,was,modifiedFactor,Obj
adjustment,wasModifiedFactorFor,associationBetweenIntakeOfB-carotene,Obj
age,was,60Years,Obj
agreement,isWith,itsMinimalSilverIonReleaseProfiles,Obj
aim,assess,diagnosticPerformanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer,Obj
aim,assess,performance,Obj
aim,provide,update,Obj
aim,provide,updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery,Obj
Aims,assess,brd4Regulation,Obj
AION,allowed,tumorImaging,Obj
AION,allowedTumorImaging,evidencedByIncreaseInContrastAfterInjection,Obj
AION,demonstratedIn,imaging,Obj
AION,generated,strongContrastWithImagingModalities,Obj
AION,were,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles,Obj
alternativeContrast-enhancedScreeningTools,are,asResultAreUsed,Obj
amount,was,825Ml,Obj
analysis,numberOf,processing,Obj
Anthracyclines,are,agents,Obj
Anthracyclines,are,mostCommonAgentsUsedInBreastCancerTreatment,Obj
anti-her2Therapies,haveChanged,aggressiveCourseOfHer2Cancer,Obj
anti-her2Therapy,isIn,patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction,Obj
article,give,overview,Obj
article,give,overviewOfAbbreviatedBreastMriProtocols,Obj
article,is,protected,Obj
article,isProtectedBy,copyright,Obj
association,has,hasInconsistent,Obj
association,isIn,particular,Obj
availableContrastAgents,are,howeverNon-ideal,Obj
BACKGROUND,determinedBy,multipleFactors,Obj
BACKGROUND,remainsDespite,trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology,Obj
barcodeMode,was,established,Obj
barcodeMode,wasEstablishedBasedOn,sixGlycosylationSites,Obj
betterUnderstanding,willAidIn,formulationOfEffectiveManagementPlanForAt-riskWomen,Obj
binding,using,imaging,Obj
binding,using,infraredFluorescentImagingInTripleNegativeInVitro,Obj
biomarker,isIn,patientsWithBreastCancerReceivingWithAnthracyclines,Obj
brcanessPhenotype,isIn,brca1Wild-typeTnbcCells,Obj
brd4Inhibition,induced,reduction,Obj
brd4PharmacologicalInhibition,moreoverInduced,dose-dependentReductionInBrca1Levels,Obj
brd4Regulation,exploreStrategiesThrough,combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer,Obj
Breast,isIn,second,Obj
breast,mriOfIs,mostSensitiveTestForBreastCancerDetection,Obj
breast,traumaticNeuromaOfIs,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate,Obj
breastCancer,is,accomplished,Obj
breastCancer,is,cancer,Obj
breastCancer,is,mostCommonCancer,Obj
breastCancer,is,mostInvasiveDisease,Obj
breastCancer,is,recognized,Obj
breastCancer,is,veryComplexDisease,Obj
breastCancer,isMostCommonCancerAmong,women,Obj
breastCancer,isMostCommonCancerIn,women,Obj
breastCancer,isMostInvasiveDiseaseNextTo,lungCancerInHuman,Obj
breastCancer,isRecognizedAs,heterogeneousCancerInFemalePatientsWorldwide,Obj
breastCancer,isVeryComplexAndHeterogeneousDiseaseWith,variableMolecularMechanismsOfCarcinogenesis,Obj
breastCancer,was,reported,Obj
breastCancerDiagnosis,isIn,familyImpact,Obj
breastImagingModality,address,issues,Obj
breastImagingModality,address,issuesOfExistingContrastAgents,Obj
breastNeuromas,areLesions,haveReported,Obj
cancer,is,complex,Obj
cancerRiskPerception,areFactors,mustAddressedDuringCancerGeneticCounselingConsultations,Obj
cancerRiskPerception,overallAreImportantFactors,mustAddressedDuringCancerGeneticCounselingConsultations,Obj
cardiacTroponins,are,used,Obj
cardiacTroponins,areUsedIn,diagnosisOfAcuteCoronarySyndromes,Obj
case,underlines,necessity,Obj
cases,were,analyzed,Obj
clinicalBreastExamination,are,howeverUnderutilized,Obj
clinicians,exploitParpTreatmentsIn,widerPopulationOfTnbcPatients,Obj
cohortStudy,reported,risk,Obj
collectedSignatures,predict,outcomesOfEstrogenReceptorPositive,Obj
collectedSignatures,were,designed,Obj
collectedSignatures,were,notablyDesigned,Obj
colorectalCancer,isIn,relativesOfPatientsWithPa,Obj
Comparison,isWith,cxcr4ExpressionDeterminedByImmunohistochemistry,Obj
Comparison,was,performed,Obj
components,include,apoptosis,Obj
components,include,cellCycleRegulators,Obj
comprehensiveSearch,was,performedFromInceptionToJanuary312018,Obj
conservativeTreatment,is,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling,Obj
contraceptionUse,has,hasFound,Obj
contrastAgents,are,non-ideal,Obj
conventionalX-rayMammography,has,lowDiagnosticSensitivityForWomenWithDenseBreasts,Obj
cornerstone,defines,value,Obj
coxHazardRegressionModels,were,used,Obj
coxProportionalHazardRegressionModels,calculateConfidenceIntervalsFor,associationBetweenPost-diagnosisLow-doseAspirinUse,Obj
coxProportionalHazardRegressionModels,were,used,Obj
cTn,have,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab,Obj
cTn,isIn,preclinicalPhase,Obj
ctnLevels,is,related,Obj
currentDevelopments,isIn,targetedImmuneCell,Obj
CXCR4,frequentlyOverexpressedIn,invasiveBreastCancer,Obj
CXCR4,overexpressedIn,breastCancer,Obj
CXCR4,overexpressedIn,invasiveBreastCancer,Obj
cxcr4-targetedPetImaging,using,68Ga-Pentixafor,Obj
decreases,isIn,bcMortalityRates,Obj
detection,isIn,women,Obj
detection,wouldFacilitate,diagnosis,Obj
detectionofBreastCancer,is,accomplished,Obj
detectionofBreastCancer,isAccomplishedBy,x-rayMammography,Obj
development,hasLedIn,decades,Obj
development,hasLedTo,decreasesInBcMortalityRates,Obj
development,isPromisingFor,imaging,Obj
diagnosticEvaluation,are,discussed,Obj
diagnosticPerformance,using,recentlyIntroducedCxcr4-targetedPetProbe68ga-pentixafor,Obj
differentialDiagnosis,isIn,patientsWithHistoryOfBreastSurgery,Obj
differentStudies,are,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer,Obj
directRelationship,was,confirmed,Obj
directRelationship,wasConfirmedIn,tnbcCells,Obj
discovery,is,needed,Obj
discovery,is,urgentlyNeeded,Obj
disease,is,present,Obj
dose-dependentReduction,isIn,brca1Levels,Obj
doses,isIn,combination,Obj
Efforts,develop,abbreviatedMriProtocols,Obj
Efforts,develop,mriProtocols,Obj
evaluation,are,discussed,Obj
excision,is,necessary,Obj
experiences,comeWith,breastCancerDiagnosis,Obj
familialCancerClustering,isIn,patientsWithProlactinoma,Obj
features,classify,images,Obj
femalePatients,are,moreCommonlyDiagnosed,Obj
femalePatients,areMoreCommonlyDiagnosedBefore,ageOf25Years,Obj
filipinoWomen,incorporate,theirExperiencesLivingWithSister,Obj
five,were,amongThemNewlyIdentifiedInStudy,Obj
five,were,identified,Obj
fluorescenceImagingExVivo,confirmed,results,Obj
follow-up,was,25Months,Obj
forty-threeCases,were,analyzed,Obj
furtherDevelopment,isPromisingFor,advancedDiagnosticImaging,Obj
furtherResearch,is,needed,Obj
healthcarePolicyMakers,curbing,use,Obj
healthcarePolicyMakers,curbing,useOfAdvancedImagingExaminations,Obj
herDisease,relapsedWith,chestWallLesions,Obj
herDisease,unfortunatelyRelapsedLaterWith,chestWallLesions,Obj
herPresentation,requiring,additionalAnti-her2Therapy,Obj
herPresentation,was,unusual,Obj
higher,diagnosedLaterIn,life,Obj
higherResolution,isIn,riskStratification,Obj
higherSuvmax,isIn,patients,Obj
highIndex,is,required,Obj
homologousRecombinationPathway,induced,brcanessPhenotypeInBrca1Wild-typeTnbcCells,Obj
hormonalContraceptionUse,has,inLongTermHasFound,Obj
I2,=,375Percecnt,Obj
I2,=,387Percecnt,Obj
identification,mayEnable,effectiveDiagnosisOfBreastCancer,Obj
identification,mayEnable,treatment,Obj
identification,would,thusWouldCrucialForApplicationOfPreventiveStrategies,Obj
imagingTechnique,requires,differentContrastAgent,Obj
importantCornerstone,definesValueAs,patient'sOutcomeOverCosts,Obj
improvedBreastCancerOs,isWith,summaryHazardRatioOf070ForHighestIntake,Obj
improvedDetection,wouldFacilitate,diagnosisOfResponseToTreatment,Obj
increase,isIn,contrastAfterInjection,Obj
increase,isIn,dnaDamage,Obj
Information,wasObtainedFrom,nationwideRegistries,Obj
initialResults,isWith,abbreviatedMriProtocols,Obj
intake,assessing,diet,Obj
involved,be,involved,Obj
involved,was,found,Obj
involved,wasRecentlyFound,involvedInDnaDamageRegulation,Obj
IORT,explained,amount,Obj
IORT,explained,amountOfObservedVariationInSeromaProduction,Obj
it,accumulatedIn,breastTumor,Obj
it,is,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer,Obj
it,is,implemented,Obj
it,is,responsible,Obj
it,is,transferable,Obj
it,seems,feasible,Obj
it,similarlyAccumulatedAfter,intravenousAdministrationOfOsteopontin-750Probe,Obj
lesion,be,missed,Obj
lesion,beMissedOn,imagingInvestigations,Obj
locoregionalRadiotherapy,is,generallyReserved,Obj
locoregionalRadiotherapy,isGenerallyReservedFor,managementOfTumour-relatedSymptoms,Obj
longScanTime,howeverLimit,itsWidespreadUse,Obj
longScanTime,limit,itsWidespreadUse,Obj
lowCtnLevels,is,related,Obj
lowCtnLevels,isRelatedTo,betterOutcomeWithGoodNegativePredictiveValue,Obj
lungCancer,isIn,human,Obj
lungCancer,was,reported,Obj
lungCancer,wasReported,significantlyHigherThanInFamiliesOfNfpaPatients,Obj
mammographicImages,using,neuralNetworkClassifier,Obj
Mammography,is,mostEffectiveTechniqueused,Obj
Mammography,isMostEffectiveAndEfficientTechniqueusedFor,detectionOfBreastCancerInWomen,Obj
manyFeatures,classifyImagesInto,harmfulorHarmlessTissues,Obj
markedReduction,isIn,costOfMriExamination,Obj
medianAge,was,60Years,Obj
medianAmount,was,825Ml,Obj
medianFollow-up,was,25MonthsFromDiagnosis,Obj
membraneTypeMannoseReceptor,was,expressed,Obj
membraneTypeMannoseReceptor,was,highlyExpressed,Obj
membraneTypeMannoseReceptor,wasHighlyExpressedIn,breastCancerPatientsSerum,Obj
membraneTypeMr,be,used,Obj
membraneTypeMr,wasDifferentiallyExpressedIn,fourTypesOfBreastCancer,Obj
Metastases,were,visuallyDetectable,Obj
Metastases,wereVisuallyDetectableIn,allFiveCases,Obj
metastaticDisease,withCasesIs,56Percecnt,Obj
moreSpecificApplications,isIn,therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments,Obj
most,was,due,Obj
MRI,is,mostSensitiveTest,Obj
MRI,is,test,Obj
mriProtocols,have,haveIntroduced,Obj
mriTechniques,are,areInvestigated,Obj
msotImaging,demonstrated,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo,Obj
msotImaging,provided,high-resolutionImages,Obj
msotImaging,provided,images,Obj
multiresolutionResult,generate,malign,Obj
mutations,isIn,BRCA1,Obj
necessity,considerNeuromaIn,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery,Obj
neuroma,is,rare,Obj
novelPowerfulTechnique,finallyIsEmergingAs,preciseToolForTargetedTreatmentOfCancerIncludingBc,Obj
novelPowerfulTechnique,isEmergingAs,preciseToolForTargetedTreatmentOfCancerIncludingBc,Obj
novelTargetedTherapeuticOptions,have,moreRecentlyHaveDeveloped,Obj
numerousGene-expression-basedPrognosticSignatures,were,developed,Obj
numerousGene-expression-basedPrognosticSignatures,wereDevelopedIn,particular,Obj
observationalStudies,haveProvided,inconsistentResults,Obj
observedVariation,isIn,seromaProduction,Obj
options,have,haveDeveloped,Obj
osteopontin-750Accumulation,using,MSOT,Obj
osteopontin-750Accumulation,usingMsotWith,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging,Obj
osteopontin-750Accumulation,was,evaluatedInVivo,Obj
osteopontin-basedProbe,demonstrated,bindingToBreastCancerCellsInVitro,Obj
ourFindings,suggest,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer,Obj
ourLiteratureReview,yielded,only35Cases,Obj
ourLiteratureReview,yielded,only35CasesOfTraumaticBreastNeuromas,Obj
patient,as,outcomeOverCosts,Obj
patient,had,oneYear,Obj
patient,had,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction,Obj
patient,moreImportantlyHad,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction,Obj
patientDemographics,were,recorded,Obj
patients,are,diagnosed,Obj
patients,isIn,outpatientClinic,Obj
patients,isWith,breastCancer,Obj
patients,isWith,PA,Obj
Patients,isWith,previousBreast/axillarySurgery,Obj
patients,isWith,unresectedLocallyAdvancedBreastCancer,Obj
patients,received,IORT,Obj
patients,received,NAC,Obj
patients,were,diagnosed,Obj
patients,were,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory,Obj
Patients,were,stratified,Obj
Patients,wereStratifiedBasedOn,presenceOfMetastaticDiseaseAtPresentation,Obj
People,areAt,risk,Obj
percecnt,are,breastCancers,Obj
percecnt,had,familyMember,Obj
percecntConfidenceIntervals,were,estimated,Obj
petImaging,patientsWith,firstDiagnosisOfBreastCancer,Obj
petImaging,using,68Ga-Pentixafor,Obj
pharmacologicalInduction,isIn,brca1Wild-typeTripleNegativeBreastCancer,Obj
postmenopausalPatient,isWith,historyOfBreast-conservingSurgery,Obj
probe,demonstrated,binding,Obj
prolongedRecovery,delayOf,radiotherapy,Obj
radicalSurgicalApproaches,isIn,breastCancer,Obj
radiotherapy,may,mayUsed,Obj
radiotherapy,may,mayUsedForTumourShrinkagePriorToSurgery,Obj
recentDanishCohortStudy,reported,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers,Obj
relationship,was,confirmed,Obj
repair,is,complex,Obj
research,is,needed,Obj
respondents,compare,themselves,Obj
results,are,consistent,Obj
results,are,largelyConsistent,Obj
results,areLargelyConsistentWith,previousStudies,Obj
RESULTS,metIn,total,Obj
results,suggest,familialCancerClusteringInPatientsWithProlactinoma,Obj
risk,hasRemained,similar,Obj
risk,is,shaped,Obj
risk,isIn,currentUsersOfLongerDuration,Obj
role,isIn,patientsWithLabc,Obj
screeningBehavior,areFactors,mustAddressed,Obj
screeningTools,are,areUsed,Obj
segmentationAlgorithm,is,applied,Obj
segmentationAlgorithm,isAppliedAfter,enhancementOfImage,Obj
selectiveBinding,was,identified,Obj
seromaFormation,using,woundDrainsPlacedInBreast,Obj
seromaFormation,was,measured,Obj
seromaProduction,isIn,primaryBreastCancerPatientsTreatedBetween01012010,Obj
seromaProduction,medianAmountOfWas,825Ml,Obj
she,onlyReceived,fiveDosesOfAdjuvantTranstuzumab,Obj
she,received,fiveDoses,Obj
she,received,fiveDosesOfAdjuvantTranstuzumab,Obj
She,received,neoadjuvantAnti-her2Treatment,Obj
She,received,treatment,Obj
She,receivedTreatmentFor,stageIiiBreastCaner,Obj
signalIntensity,was,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively,Obj
signalIntensity,was,greater,Obj
signature,is,strong,Obj
signatures,were,developed,Obj
significantAdvances,isIn,screening,Obj
similarTowaveletFilter,are,sensitive,Obj
similarTowaveletFilter,areSensitive,moreDirectional,Obj
smallMoleculeInhibitors,target,specificCancerCell-relatedComponents,Obj
standardizedImagingProtocol,are,necessary,Obj
strongAssociation,isIn,particular,Obj
strongContrast,isWith,imagingModalities,Obj
studies,are,necessary,Obj
studies,haveProvided,results,Obj
studies,wereIncludedIn,meta-analysis,Obj
study,collect,familyHistory,Obj
study,collectFamilyHistoryIn,largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic,Obj
study,indicates,potential,Obj
study,indicates,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis,Obj
study,sought,understand,Obj
subcutaneousBreastTumor,isIn,nudeMice,Obj
subjectiveRisk,is,alsoShaped,Obj
subjectiveRisk,isAlsoShapedBy,theirBeliefsRegardingCancerCausation,Obj
subtype-specificSignature,is,strongIndependentPrognosticFactor,Obj
subtype-specificSignature,isStrongAndSignificantIndependentPrognosticFactorIn,correspondingCohort,Obj
summaryHazardRatios,using,randomEffectsModel,Obj
surgicalExcision,is,necessary,Obj
surgicalExcision,isNecessary,mayIndicativeOfBenignLesion,Obj
tenStudies,were,included,Obj
the,be,misdiagnosis,Obj
theirAbility,isIn,theirOriginallyTargetedPopulationsOfBreastCancer,Obj
theirCardiotoxicities,are,concerns,Obj
theirCardiotoxicities,are,majorConcerns,Obj
theirCardiotoxicities,areMajorConcernsInSpiteOf,therapeuticBenefits,Obj
theirEmergingRole,isIn,newValue-basedHealthcareParadigm,Obj
theirInhibition,induced,brcanessPhenotype,Obj
theResulting,be,misdiagnosis,Obj
theResulting,beMisdiagnosisDueTo,humanErrors,Obj
They,didFind,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings,Obj
they,have,strongFamilyHistoryOfCancer,Obj
third-degree,were,reportedInSignificantlyHigherProportionOfPatientsWithPa,Obj
time,limit,itsUse,Obj
TNBC,been,soFarHasMainlyAssociatedWithMutationsInBrca1,Obj
TNBC,is,additionalIndicator,Obj
TNBC,is,indicator,Obj
TNBC,isAdditionalIndicatorOf,mutationalStatusBesidesFamilyHistory,Obj
Transcripts,using,thematicAnalysis,Obj
Transcripts,were,analyzed,Obj
traumaticBreastNeuromas,areLesions,haveReportedMainlyAfterMastectomy,Obj
traumaticBreastNeuromas,areVeryRareBenignLesions,haveReportedMainlyAfterMastectomy,Obj
traumaticNeuroma,is,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate,Obj
treatment,is,feasible,Obj
troponins,are,used,Obj
tumorDetectability,howeverIsSignificantlyLowerComparedTo,18f-fdgPet,Obj
tumorDetectability,is,howeverSignificantlyLower,Obj
tumor-to-backgroundRatios,were,measured,Obj
Ulceration,improvedFollowing,radiotherapy,Obj
understanding,willAidIn,formulation,Obj
unenhancedMriTechniques,are,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis,Obj
use,has,hasApplied,Obj
use,has,thereforeHasAppliedToEarlyIdentification,Obj
we,analyzed,23Studies,Obj
we,analyzed,glycosylation,Obj
we,analyzed,glycosylationOfMembraneTypeMr,Obj
we,assume,expressed,Obj
We,conjugated,osteopontinPeptide,Obj
We,conjugatedOsteopontinPeptideTo,infraredFluorescentDye,Obj
we,defined,aspirinUse,Obj
we,defined,time-varyingPost-diagnosisLow-doseAspirinUse,Obj
We,discussed,management,Obj
we,examined,associationBetweenPost-diagnosisUseOfLow-doseAspirin,Obj
we,herePresent,elderlyPatientWithRelapsedHer2,Obj
We,identify,signatures,Obj
We,identify,subtype-specificPrognosticSignatures,Obj
We,present,case,Obj
we,present,elderlyPatientWithRelapsedHer2,Obj
we,present,patient,Obj
We,present,veryRareCaseOfTraumaticBreastNeuroma,Obj
We,reviewed,ourExperience,Obj
We,reviewed,ourExperienceOfHigh-doseRadiotherapy,Obj
we,separatelyAssessed,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer,Obj
we,summarized,signatures,Obj
we,thereforeSystematicallyAnalyzedGlycosylationBy,massSpectrometry,Obj
We,treated,patient,Obj
We,treatedPatientWith,lapatinibCombined,Obj
women,developed,CBC,Obj
women,isWith,breastCancer,Obj
women,isWith,denseBreasts,Obj
youngPatients,isWith,PA,Obj
a,b,c
c,b,a
c,b,d
a,testPred,a
a,b,a